1. Home
  2. SND vs LCTX Comparison

SND vs LCTX Comparison

Compare SND & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

N/A

Current Price

$3.82

Market Cap

215.0M

Sector

Industrials

ML Signal

N/A

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.02

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SND
LCTX
Founded
2011
1990
Country
United States
United States
Employees
318
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.0M
251.4M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
SND
LCTX
Price
$3.82
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
199.0K
★ 1.4M
Earning Date
11-20-2026
11-12-2026
Dividend Yield
★ 6.39%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.15
N/A
Revenue
★ $330,153,000.00
$14,556,000.00
Revenue This Year
N/A
$4.38
Revenue Next Year
N/A
$10.80
P/E Ratio
$29.13
★ N/A
Revenue Growth
6.03
★ 53.24
52 Week Low
$2.09
$0.88
52 Week High
$5.92
$1.99

Technical Indicators

Market Signals
Indicator
SND
LCTX
Relative Strength Index (RSI) 21.77 54.42
Support Level $3.64 $1.02
Resistance Level $5.39 $1.05
Average True Range (ATR) 0.24 0.06
MACD -0.12 0.00
Stochastic Oscillator 3.62 72.53

Price Performance

Historical Comparison
SND
LCTX

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics. The company has two reportable segments, Sand and SmartSystems. It derives maximum revenue from Sand segment, which includes both frac sand sales and IPS sales. Geographically, the company derives maximum revenue from United States, followed by Canada.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: